Why Choose Methylphenidate ER
Methylphenidate ER tablets are a generic formulation of branded methylphenidate HCl extended-release tablets indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) for people aged 13 to 65.2
- CONVENIENCE Once-daily Methylphenidate ER is available in a range of dosing options to better suit a patient’s needs
- FEWER TABLETS Taking fewer tablets may reduce out-of-pocket costs when prescription plans impose quantity limits
- SAME APPEARANCE Each prescription fill looks the same because it comes from the same manufacturer
- AFFORDABILITY As a generic drug, patients may have expanded access and lower costs
Now Offering “In-Between” Doses
Methylphenidate ER is now available in 45-mg and 63-mg tablets. These “in-between” doses allow for more targeted titration in a single once-daily tablet. Therapy can be tailored to the patient's needs without them having to take more pills each day.
References: 1. Methylphenidate hydrochloride extended-release tablets [package insert]. Trigen Laboratories, LLC; 2022. 2. Data on file, Osmotica Pharmaceutical US LLC.
*Co-pay cards are available for prescription coverage assistance for qualified patients. For terms and conditions, click here. Offer void where prohibited. Other restrictions apply. The use of this Savings Card is limited to prescriptions of Methylphenidate ER 45-mg, 63-mg and 72-mg tablets.